Literature DB >> 22388444

A review of three commonly prescribed skeletal muscle relaxants.

R N Harden1, C Argoff.   

Abstract

Skeletal muscle relaxants (SMR) are commonly used drugs prescribed for the treatment of muscle spasm and discomfort. Although many have been in use for decades, physicians may be unaware of the accumulating evidence of their risks, benefits, safety and side effects. This review examines the efficacy, side effects, and safety of three commonly prescribed SMRs: metaxalone, cyclobenzaprine, and carisoprodol. All three appear to have equal efficacy, but their side effects vary considerably. Metaxalone has the fewest reports of side effects, and no reports of major safety issues. Cyclobenzaprine, closely related to the tricyclic antidepressants, causes the expected lethargy and anticholinergic side effects, and may have some toxicity in overdose and in combination with other substances. Carisoprodol raises the greatest concern. Reports in the literature suggest a significant potential for physical and psychological dependence perhaps suggesting a potential for misuse. It also has, perhaps, the greatest toxicity. A secondary goal of this review is to stimulate more discourse about these commonly used, but poorly understood compounds.

Entities:  

Year:  2000        PMID: 22388444     DOI: 10.3233/bmr-2000-152-303

Source DB:  PubMed          Journal:  J Back Musculoskelet Rehabil        ISSN: 1053-8127            Impact factor:   1.398


  3 in total

Review 1.  Herbal medicine for low-back pain.

Authors:  Hanna Oltean; Chris Robbins; Maurits W van Tulder; Brian M Berman; Claire Bombardier; Joel J Gagnier
Journal:  Cochrane Database Syst Rev       Date:  2014-12-23

2.  Comparison of the dissolution of metaxalone tablets (Skelaxin) using USP Apparatus 2 and 3.

Authors:  Janice Cacace; Eugene E Reilly; Anton Amann
Journal:  AAPS PharmSciTech       Date:  2004-02-06       Impact factor: 3.246

3.  Development of a Stability-Indicating RP-UPLC Method for Rapid Determination of Metaxalone and its Degradation Products in Solid Oral Dosage Form.

Authors:  Rakshit Kanubhai Trivedi; Mukesh C Patel
Journal:  Sci Pharm       Date:  2012-02-21
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.